Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Charles Berabose
Institution:
Rwanda Biomedical Center
Observed institutions:
Rwanda Biomedical Center,
Ministry of Health
ORCID:
0009-0006-3669-0826
Observed ORCID:
0009-0006-3669-0826
OpenAlex ID:
A5116068056
Introducing Sofosbuvir/Velpatasvir + Ribavirin as a Generic Retreatment Regimen for Hepatitis C: Evaluation of a Government Program in Rwanda
2025
·
Janvier Serumondo
, Peter Barebwanuwe
, et al.
·
Clinical Infectious Diseases
·
4
All‐Cause Mortality in Persons With HIV ‐ HBV Co‐Infection Treated for HBV in Rwanda: A Population‐Based Cohort Study
2026
·
Jean Damascene Makuza
, Michael Law
, et al.
·
Journal of Viral Hepatitis
·
1
PDF
Assessing the Status of and Impediments to Achieving the WHO Goal to Eliminate Viral Hepatitis B by 2030: A Scoping Review
2026
·
Charles Berabose
, Ralf Clemens
, et al.
·
Vaccines
Hepatitis B treatment response and factors associated with HBV treatment success: A population-based study in Rwanda
2026
·
Jean Damascene Makuza
, Michael Law
, et al.
·
Hepatology Communications
Show more works
View as search
Works count:
4
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type
